BIOCHEMICAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE PATIENTS

被引：0
作者：
Romanova, Valentyna [1 ]
机构：
[1] Natl Pirogov Mem Med Univ, Vinnytsya, Ukraine
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2018年 / 32卷
关键词：
D O I：
10.1016/j.atherosclerosissup.2018.04.356
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P3.097
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
[31]   Increasing Endothelial Dysfunction Markers Level are Associated with the Incidence of Heart Failure in Patients with Acute Coronary Syndrome [J].
Kosaki, Ryota ;
Minoura, Yoshino ;
Tsukamoto, Shigeto ;
Nomura, Kosuke ;
Sakai, Koshiro ;
Kondo, Seita ;
Tsujita, Hiroaki ;
Hamazaki, Yuji ;
Kobayashi, Youichi .
JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) :S173-S173
[32]   Endothelial function in patients with cardiovascular diseases. Part II: endothelial dysfunction in patients with hypertension and coronary heart disease [J].
Poreba, Rafal ;
Derkacz, Arkadiusz ;
Poreba, Malgorzata ;
Andrzejak, Ryszard .
ARTERIAL HYPERTENSION, 2006, 10 (02) :147-152
[33]   Endothelial dysfunction and inflammation in patients with coronary artery disease [J].
Lopez-Jaramillo, P ;
Cubillos, LA ;
Casas, JP ;
Silva, F ;
Oubina, MP ;
Cachofeiro, V ;
Lahera, V .
JOURNAL OF HYPERTENSION, 2004, 22 :S250-S250
[34]   Endothelial dysfunction and coronary artery disease in patients with COPD [J].
MacLeod, Mairi ;
Knott, Kristopher ;
Lopez, Ralph ;
Bartlett-Pestell, Sam ;
Braddy-Green, Aaron ;
Khamis, Ramzi Y. ;
Barnes, Peter J. ;
Collins, Peter ;
Nicol, Ed D. ;
Wedzicha, Jadwiga A. ;
Paschalaki, Koralia .
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[35]   Biochemical coronary heart disease risk markers in young black women [J].
Davis, EE ;
Huffman, FG .
FASEB JOURNAL, 2005, 19 (05) :A1037-A1037
[36]   Measures of chronic heart failure as the markers of cognitive dysfunction in patients with coronary heart disease complicated by circulatory failure [J].
Akimova, Natalya S. ;
Bugaeva, Oksana, V ;
Konshina, Larisa E. ;
Shvarts, Yury G. .
COR ET VASA, 2021, 63 (01) :20-24
[37]   Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease [J].
Robinson, SD ;
Ludlam, CA ;
Boon, NA ;
Newby, DE .
HEART, 2006, 92 (02) :170-176
[38]   Functional interplay between endothelial dysfunction and platelet activation in patients with stable coronary heart disease [J].
Robinson, SD ;
Harding, SA ;
Cummins, P ;
Sarma, J ;
Davidson, I ;
Fox, KA ;
Boon, NA ;
Newby, DE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :450A-450A
[39]   HYPERRESISTINEMIA IS AN INDEPENDENT RISK FACTOR FOR ENDOTHELIAL DYSFUNCTION AND ANGIOGRAPHIC EXTENT IN PATIENTS WITH CORONARY HEART DISEASE [J].
Huang, X-S ;
Pu, X-Q .
ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[40]   Impact of Hypertriglyceridemia on Endothelial Dysfunction During Statin ± Ezetimibe Therapy in Patients With Coronary Heart Disease [J].
Yunoki, Kei ;
Nakamura, Kazufumi ;
Miyoshi, Toru ;
Enko, Kenki ;
Kubo, Motoki ;
Murakami, Masato ;
Hata, Yoshiki ;
Kohno, Kunihisa ;
Morita, Hiroshi ;
Kusano, Kengo F. ;
Ito, Hiroshi .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (03) :333-339
12345